Ming Shyan Huang | Health Professions | Best Researcher Award

Posted on by ScienceFather

Prof. Ming Shyan Huang | Health Professions | Best Researcher Award

MD,PhD at E-Da Cancer Hospital, Taiwan

Dr. Ming-Shyan Huang, MD, PhD, FCCP, FIAC, is a distinguished professor and medical researcher specializing in internal medicine, with a primary focus on lung cancer, airway diseases, and critical care. He currently serves as the Deputy Minister of E-Da Healthcare Group and a professor at the Department of Internal Medicine, School of Medicine, I-Shou University. With decades of experience in both clinical practice and academic research, Dr. Huang has contributed significantly to medical advancements through his leadership roles and research initiatives. His career spans multiple prestigious institutions, including Kaohsiung Medical University, Tokyo Medical University, and Mayo Clinic, where he gained international exposure and developed expertise in pulmonary medicine. Recognized with multiple outstanding research awards, he has demonstrated excellence in medical research, patient care, and healthcare management. His work has influenced both national and international medical communities, reflecting his commitment to advancing internal medicine. With extensive experience in hospital administration, academic mentorship, and groundbreaking research, Dr. Huang continues to make significant contributions to the field of respiratory medicine. His leadership and expertise place him among the top medical researchers in Taiwan and beyond, making him a strong candidate for prestigious research awards.

Professional Profile

Education

Dr. Ming-Shyan Huang’s educational journey is marked by prestigious degrees and international research training. He earned his Doctor of Medicine (MD) from Kaohsiung Medical University, Taiwan, in 1977, laying the foundation for his career in internal medicine. He further pursued a Doctor of Philosophy (PhD) in Internal Medicine from Tokyo Medical University, Japan, in 1986, where he developed specialized expertise in pulmonary medicine. His academic pursuits extended beyond Taiwan and Japan, as he engaged in advanced research training at globally recognized institutions. From 1987 to 1988, he worked as a visiting researcher at Mayo Clinic in Rochester, Minnesota, USA, gaining valuable experience in clinical research and respiratory medicine. His international exposure continued in 1993–1994 when he undertook a postdoctoral fellowship in the Division on Aging, Department of Medicine, at the University of Arkansas for Medical Sciences, USA. His diverse and rigorous academic training across Taiwan, Japan, and the United States provided him with a comprehensive foundation in internal medicine and critical care research. These educational experiences have equipped him with the necessary knowledge and skills to lead cutting-edge research in pulmonary diseases and contribute to advancements in medical science.

Professional Experience

Dr. Ming-Shyan Huang has held various prestigious academic and administrative positions throughout his career, demonstrating his leadership in medical research and healthcare. Since January 2021, he has served as the Deputy Minister of E-Da Healthcare Group while continuing his role as a professor at the Department of Internal Medicine, I-Shou University. From 2017 to 2020, he was the Vice Superintendent of E-Da Cancer Hospital, where he played a crucial role in managing internal medicine services. Prior to this, he spent several years at Kaohsiung Medical University, where he held multiple leadership roles, including Director of the Division of Geriatrics and Gerontology (2010–2017) and Vice Superintendent of Medicine (2009–2011). His tenure at Kaohsiung Medical University also included serving as Director of the Department of Internal Medicine (2006–2009) and Professor of Internal Medicine (1999–2017). Earlier in his career, he was the Director of the Division of Chest Medicine (1997–2004) and an Associate Professor (1988–1999) at Kaohsiung Medical College Hospital. His extensive professional experience in academia, research, and hospital administration highlights his contributions to internal medicine, particularly in respiratory diseases and critical care.

Research Interests

Dr. Ming-Shyan Huang’s research interests focus on lung cancer, airway disease, and critical care, making significant contributions to respiratory medicine. His work in lung cancer explores innovative diagnostic and therapeutic approaches, aiming to improve early detection and treatment strategies. He is also deeply involved in airway disease research, including chronic obstructive pulmonary disease (COPD) and asthma, investigating novel interventions to enhance patient outcomes. His critical care research examines advanced methods for managing severe respiratory conditions, particularly in intensive care settings. Dr. Huang’s interdisciplinary approach integrates clinical practice with laboratory research, ensuring that his findings translate into practical medical applications. His international research experiences at Mayo Clinic and the University of Arkansas have further enriched his expertise in these areas. Additionally, he collaborates with various institutions to develop new medical protocols and improve healthcare systems. His dedication to pulmonary medicine research has led to numerous publications and advancements in respiratory disease management. With a focus on translational medicine, he continues to bridge the gap between scientific discovery and clinical implementation, contributing to the global medical community.

Research Skills

Dr. Ming-Shyan Huang possesses a diverse set of research skills that have contributed to his success in the field of internal medicine. His expertise includes clinical research methodologies, allowing him to conduct in-depth studies on lung cancer, airway diseases, and critical care. He is proficient in advanced diagnostic techniques, including imaging, biomarker analysis, and pulmonary function testing, which are crucial for early disease detection and treatment evaluation. His experience in statistical data analysis enables him to interpret complex clinical trial results and derive meaningful conclusions. Additionally, he has strong skills in grant writing and securing research funding, which have supported his various medical investigations. His collaborative research approach involves working with multidisciplinary teams across different institutions, facilitating knowledge exchange and innovation. He is also skilled in mentoring young researchers and medical professionals, fostering the next generation of scientists in internal medicine. His ability to integrate laboratory research with clinical applications ensures that his findings have a direct impact on patient care. With a strong foundation in experimental design, data interpretation, and academic publishing, Dr. Huang continues to advance medical research in pulmonary and critical care medicine.

Awards and Honors

Dr. Ming-Shyan Huang has received multiple awards and honors recognizing his contributions to medical research and healthcare. He has been honored with the Outstanding Research Award from Kaohsiung Medical University on three occasions, in 2012, 2013, and 2014, highlighting his sustained excellence in scientific investigations. In 2020, he was awarded the Outstanding Research Award from E-Da Hospital, I-Shou University, further acknowledging his impact on medical advancements. These awards reflect his dedication to improving diagnostic and therapeutic approaches in internal medicine, particularly in lung cancer and airway diseases. His research has been widely recognized within Taiwan and internationally, underscoring his leadership in respiratory medicine. Beyond institutional recognition, his work has contributed to major developments in patient care and medical protocols, benefiting both academic research and clinical practice. His numerous accolades serve as a testament to his commitment to excellence in research and innovation in pulmonary medicine. With a distinguished career spanning multiple decades and institutions, Dr. Huang’s achievements continue to influence the field of internal medicine and set a high standard for medical research.

Conclusion

Dr. Ming-Shyan Huang is an accomplished researcher and medical professional with a profound impact on internal medicine, particularly in lung cancer, airway diseases, and critical care. His extensive academic background, international research experience, and leadership in medical institutions demonstrate his dedication to advancing healthcare and medical science. His numerous awards, including multiple Outstanding Research Awards, highlight his significant contributions to respiratory medicine. His expertise in clinical research, innovative diagnostic techniques, and mentorship of young researchers further establish his reputation as a leader in the field. While his research impact is well-recognized, further details on his high-impact publications and international collaborations could strengthen his profile even more. Overall, his career reflects a commitment to scientific discovery and clinical excellence, making him a strong contender for prestigious research awards. His leadership in academia and hospital administration, combined with his research contributions, positions him as a key figure in pulmonary medicine. Moving forward, continued advancements in translational research and global collaborations will further solidify his influence in internal medicine.

Publication Top Notes

  1. Polygenic Risk Score and Lung Adenocarcinoma Risk Among Never-Smokers by EGFR Mutation Status

    • Authors: B. Blechter, Batel; C. Hsiung, Chao (Agnes); X. Wang, Xiaoyu; W. Tan, Wen; C. Wang, Chihliang
    • Year: 2025
    • Citations: 0

  2. Increased di-(2-ethylhexyl) phthalate exposure poses a differential risk for adult asthma clusters

    • Authors: Y. Hsu, Yuanting; C. Wu, Chaochien; C. Wang, Chinchou; M. Huang, Mingshyan; S. Huang, Shauku
    • Year: 2024
    • Citations: 1

  3. CD47-mediated immune evasion in early-stage lung cancer progression

    • Authors: C. Chuang, Chenghao; Y.Y. Zhen, Yen Yi; J.Y. Ma, Juei Yang; Y.C. Chang, Yu Chan; C. Yang, Chihjen
    • Year: 2024
    • Citations: 2

  4. Increased serum adipokines are associated with sarcopenia in non-obese women with rheumatoid arthritis

    • Authors: T. Fang, Tzujung; M. Chiu, MinhSi; M. Huang, Mingshyan; Y. Yeh, Yaotsung; J. Yen, Jenghsien
    • Year: 2024
    • Citations: 0

  5. A Lactobacillus Combination Ameliorates Lung Inflammation in an Elastase/LPS—induced Mouse Model of Chronic Obstructive Pulmonary Disease

    • Authors: H. Shen, Huanting; Y. Fang, Yiting; W. Tsai, Wanhua; B.Y. Wang, Bing Yen; W. Chang, WenWei
    • Year: 2024
    • Citations: 3

  6. Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population

    • Authors: J. Shi, Jianxin; K. Shiraishi, Kouya; J. Choi, Jiyeon; J. Park, Jaeyong; S. Kweon, Sunseong
    • Year: 2023
    • Citations: 27

  7. Low-Dose Computed Tomography Screening in Relatives With a Family History of Lung Cancer

    • Authors: C.L. Wang, Chi Liang; K.H. Hsu, Kuo Hsuan; Y. Chang, Yahsuan; Y.H. Tsai, Yiang Huang; G. Chang, Geecheng
    • Year: 2023
    • Citations: 11

  8. BTEX exposure and its body burden pose differential risks for asthma and its phenotypic clusters

    • Authors: Y. Hsu, Yuanting; C. Wu, Chaochien; C. Wang, Chinchou; M. Huang, Mingshyan; S. Huang, Shauku
    • Year: 2023
    • Citations: 3

  9. Supportive Care Needs Trajectories in Patients With Advanced Non-Small-Cell Lung Cancer Receiving Chemotherapy: A Longitudinal Study

    • Authors: C. Yen, Chunju; H. Hsu, Hsintien; H. Hsieh, Hsiufen; M. Huang, Mingshyan; P. Lin, Peichao
    • Year: 2023
    • Citations: 1

Mona Arafa | Health Professions | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Mona Arafa | Health Professions | Best Researcher Award

Faculty of Pharmacy at University of Tabuk, Saudi Arabia.

Dr. Mona Farouk Mahmoud Arafa is an accomplished Associate Professor in the Pharmaceutics Department at Tabuk University, Saudi Arabia. She earned her Ph.D. in Pharmaceutical Technology from the University of Tanta, Egypt, focusing on enhancing oral bioavailability through drug crystalline structure modification. With a solid foundation in pharmacy, she has progressed through various academic roles, from Demonstrator to Associate Professor, and actively contributes to departmental committees and quality assurance initiatives. Dr. Arafa’s research interests center on the formulation and evaluation of microemulsions, niosomes, and colloidal systems to improve transdermal drug delivery and oral absorption. She has authored numerous publications in reputable journals and has extensive experience with advanced techniques such as high-performance liquid chromatography and differential scanning calorimetry. Dr. Arafa is committed to advancing pharmaceutical sciences and education, having participated in various training programs to enhance her teaching and research capabilities.

Profile:

Education

Dr. Mona Farouk Mahmoud Arafa holds an impressive educational background in the field of pharmacy and pharmaceutical technology. She earned her Bachelor’s degree in Pharmacy from the University of Tanta, Egypt, in 2009, graduating with a general grade of “Excellent with Honor.” She then pursued her Master’s degree in Pharmaceutical Technology at the same institution, completing her thesis on the optimization of colloidal carriers for the simultaneous transdermal delivery of two drugs in 2013. Dr. Arafa continued her academic journey by obtaining her Ph.D. in Pharmaceutical Technology in 2017, also from the University of Tanta. Her doctoral research focused on the investigation of drug crystalline structure modification as a tool for enhancing oral bioavailability. This strong educational foundation has equipped Dr. Arafa with the knowledge and expertise necessary to excel in her role as an associate professor in the Pharmaceutics Department at Tabuk University, Saudi Arabia.

Professional Experience

Dr. Mona Farouk Mahmoud Arafa is an accomplished academic and researcher in the field of Pharmaceutical Technology, currently serving as an Associate Professor in the Pharmaceutics Department at Tabuk University, Saudi Arabia. She holds a Ph.D. in Pharmaceutical Technology from the University of Tanta, Egypt, where her research focused on enhancing oral bioavailability through drug crystalline structure modification. Dr. Arafa has progressively advanced through various academic ranks, starting as a Demonstrator and rising to her current position. Her administrative roles include membership in departmental councils, student affairs committees, and quality assurance units. With a strong emphasis on research, Dr. Arafa has authored numerous publications in esteemed journals, contributing to advancements in drug delivery systems, microemulsions, and transdermal formulations. Her expertise is complemented by active participation in training programs and workshops, enhancing her skills in crisis management, international publishing, and digital transformation within higher education.

Research Interest

Dr. Mona Farouk Mahmoud Arafa’s research interests lie in the field of pharmaceutical technology, with a particular focus on enhancing drug delivery systems. Her work involves the formulation, characterization, and evaluation of innovative colloidal carriers, including microemulsions and niosomes, aimed at improving transdermal drug delivery. Dr. Arafa employs advanced analytical techniques such as differential scanning calorimetry, X-ray powder diffraction, and Fourier transform infrared spectroscopy to study the modulation of crystalline structures in drugs. This research is pivotal in understanding how drug interactions with various co-processors can enhance oral bioavailability and absorption. Additionally, she investigates the applications of novel excipients and co-crystal formations to optimize drug dissolution rates. Through her comprehensive approach, Dr. Arafa contributes significantly to the development of advanced pharmaceutical formulations, striving to address challenges in drug delivery and improve therapeutic outcomes for patients.

Research Skills

Dr. Mona Farouk Mahmoud Arafa possesses a robust set of research skills that significantly contribute to her expertise in pharmaceutical technology. Her proficiency in formulating, characterizing, and evaluating various drug delivery systems, including microemulsions and niosomes, showcases her ability to innovate in the field. Dr. Arafa is adept in employing advanced analytical techniques, such as high-performance liquid chromatography, differential scanning calorimetry, and X-ray powder diffraction, to assess drug crystalline structures and enhance oral bioavailability. Her extensive publication record in peer-reviewed journals highlights her capability to conduct rigorous research, analyze complex data, and communicate findings effectively. Additionally, her experience in collaborative research and training programs underscores her commitment to academic excellence and professional development. Dr. Arafa’s skill set not only emphasizes her technical expertise but also reflects her dedication to advancing pharmaceutical sciences and improving patient outcomes through innovative drug delivery systems.

Award and Recognition

Dr. Mona Farouk Mahmoud Arafa, an esteemed Associate Professor in the Pharmaceutics Department at Tabuk University, has received numerous awards and recognitions for her exceptional contributions to pharmaceutical technology. Her groundbreaking research, particularly in the enhancement of oral bioavailability and transdermal drug delivery systems, has been published in high-impact journals, earning her a respected reputation in the academic community. Dr. Arafa’s innovative work on drug crystalline structure modification and the development of novel colloidal carriers has not only advanced scientific understanding but also significantly impacted pharmaceutical practices. She has been actively involved in training programs and workshops, fostering a culture of excellence in education and research. Additionally, her leadership roles within various academic committees reflect her commitment to quality assurance in higher education. Dr. Arafa’s dedication to her field, combined with her extensive research output, underscores her eligibility for recognition as a leading researcher in the pharmaceutical sciences.

Conclusion

Dr. Mona Farouk Mahmoud Arafa is a highly qualified candidate for the Best Researcher Award, exemplifying dedication to research, education, and academic leadership. Her extensive publications, innovative research in drug delivery systems, and administrative roles underscore her commitment to advancing pharmaceutical sciences. By addressing areas for improvement, particularly in networking and public engagement, Dr. Arafa can further elevate her contributions to the field and enhance her influence as a researcher and educator. Recognizing her with this award would not only honor her achievements but also inspire others in the academic community.

Publication Top Notes

  • Aerosil as a novel co-crystal co-former for improving the dissolution rate of hydrochlorothiazide
    • Authors: SA El-Gizawy, MA Osman, MF Arafa, GM El Maghraby
    • Year: 2015
  • Sucralose as co-crystal co-former for hydrochlorothiazide: development of oral disintegrating tablets
    • Authors: MF Arafa, SA El-Gizawy, MA Osman, GM El Maghraby
    • Year: 2016
  • Chitosan coated nanostructured lipid carriers for enhanced in vivo efficacy of albendazole against Trichinella spiralis
    • Authors: RK Eid, DS Ashour, EA Essa, GM El Maghraby, MF Arafa
    • Year: 2020
  • Xylitol as a potential co-crystal co-former for enhancing dissolution rate of felodipine: preparation and evaluation of sublingual tablets
    • Authors: MF Arafa, SA El-Gizawy, MA Osman, GM El Maghraby
    • Year: 2018
  • Co-crystallization for enhanced dissolution rate of nateglinide: In vitro and in vivo evaluation
    • Authors: MF Arafa, SA El-Gizawy, MA Osman, GM El Maghraby
    • Year: 2017
  • Microemulsion for simultaneous transdermal delivery of benzocaine and indomethacin: in vitro and in vivo evaluation
    • Authors: GM El Maghraby, MF Arafa, MA Osman
    • Year: 2014
  • Lidocaine as eutectic forming drug for enhanced transdermal delivery of nonsteroidal anti-inflammatory drugs
    • Authors: HF Marei, MF Arafa, EA Essa, GM El Maghraby
    • Year: 2021
  • Niosomal versus nano-crystalline ivermectin against different stages of Trichinella spiralis infection in mice
    • Authors: DA Elmehy, MA Hasby Saad, GM El Maghraby, MF Arafa, NA Soliman, …
    • Year: 2021

 

Sohail Adnan | Health Professions | Best Researcher Award

Posted on by ScienceFather

Assist Prof Dr. Sohail Adnan | Health Professions | Best Researcher Award 

Assistant Professor Neurology at District Headquarter Teaching Hospital KDA Kohat, Pakistan

 Assistant Professor Dr. Sohail Adnan is a consultant neurologist and academic specializing in brain function and consciousness. His research focuses on the Integrative Brain Theory and the role of neuronal networks in consciousness, particularly in the context of focal ischemic infarctions. Dr. Adnan aims to enhance diagnostic and therapeutic approaches in neurology through his work. He holds an FCPS in Neurology and has extensive experience in both clinical and academic settings. His contributions are crucial for advancing knowledge in neurology and improving patient care.

Professional Profiles:

Education

Assistant Professor Dr. Sohail Adnan completed his MBBS at Khyber Medical College, Peshawar, graduating on 2nd September 2010. He then pursued his postgraduate education in medicine, securing his FCPS in Neurology from the College of Physicians and Surgeons Pakistan on 15th May 2018. His residency included two years in General Medicine at Pakistan Atomic Energy Commission General Hospital, Islamabad (24th January 2013 to 24th January 2015), followed by three years in Neurology at Govt. Lady Reading Hospital, Peshawar (29th January 2015 to 28th January 2018). Dr. Adnan also completed six-month house jobs in General Surgery (December 2010 to May 2011) and General Medicine (June 2011 to November 2011). His early education includes Intermediate from Govt. College Peshawar and Secondary School from F.G. Boys Public High School, Peshawar Cantt.

Professional Experience

Assistant Professor Dr. Sohail Adnan has a robust background in neurology, currently serving as a Consultant Neurologist and re-designated Senior Registrar Neurology at DHQ Teaching Hospital KDA Kohat since 1st June 2018. Previously, he was appointed as a Medical Officer through the Khyber Pakhtunkhwa Public Service Commission on 11th May 2016. He has been posted at DHQ Teaching Hospital KDA Kohat since 1st February 2018. Dr. Adnan’s extensive training includes completing his FCPS in Neurology in May 2018 and his residency in General Medicine and Neurology. His hands-on experience includes six-month house jobs in General Surgery (December 2010 to May 2011) and General Medicine (June 2011 to November 2011).

Research Interest

Assistant Professor Dr. Sohail Adnan’s research interests are centered around neurology, with a particular focus on understanding brain function and consciousness. His work delves into the Integrative Brain Theory, exploring how different brain processes and networks contribute to overall consciousness. Dr. Adnan investigates how consciousness emerges from the neuronal network and examines its preservation in focal ischemic infarctions. His research aims to deepen the understanding of how brain activities and neurological disorders interact, seeking to enhance diagnostic and therapeutic methods. By focusing on the intricate mechanisms underlying neurological conditions, Dr. Adnan contributes significantly to both clinical practices and academic knowledge in neurology. His work is instrumental in advancing the field and improving patient outcomes through a more comprehensive understanding of brain function and disorders.

 Award and Honors

Assistant Professor Dr. Sohail Adnan has earned significant recognition throughout his career. He qualified for the FCPS Neurology on his first attempt in May 2018, reflecting his high level of expertise. In May 2016, he was appointed as a Medical Officer through the Khyber Pakhtunkhwa Public Service Commission, further validating his qualifications. Dr. Adnan also excelled during his house jobs in General Surgery and General Medicine. His outstanding performance in medical examinations is evident from his high grades across all professional levels. These honors highlight his exceptional skills and dedication to the field of neurology and medical practice.

Research Skills

Assistant Professor Dr. Sohail Adnan has achieved notable recognition in his field. He was awarded the prestigious Fellowship of College of Physicians and Surgeons (FCPS) in Neurology in May 2018, a testament to his exceptional expertise and dedication. His academic excellence is further demonstrated by his successful completion of the FCPS Neurology program on his first attempt. Dr. Adnan’s contributions to the field are underscored by his appointment as a Medical Officer through the Khyber Pakhtunkhwa Public Service Commission in 2016, followed by his role as a Consultant Neurologist in DHQ Teaching Hospital KDA Kohat. These honors and roles reflect his commitment to advancing neurology and his recognition as a leading expert in the discipline.

Publications
  1. “The enhanced reliability of higher National Institute of Health Stroke Scale thresholds over the conventional 6-point scale”
    Authors: Adnan, S., Nawab, S., Khan, S.U., Hussain, F.
    Journal: Clinical Neurology and Neurosurgery
    Year: 2024
    Volume: 241
    Article Number: 108284
  2. “Idiopathic unilateral third nerve palsy with pupillary sparring in a 10-year-old child – a case report”
    Authors: Khan, Q.A., Adnan, S., Ahmad, N., Iram, S., Baqi, A.
    Journal: Annals of Medicine and Surgery
    Year: 2022
    Volume: 82
    Article Number: 104723
  3. “Consciousness emanates from the neuronal network of coordination, a fact endorsed by preserved consciousness in focal ischemic infarctions”
    Authors: Adnan, S., Shah, M., Shah, S.F., Ali, A., Hamid, M.
    Journal: NeuroQuantology
    Year: 2021
    Volume: 19(3)
    Pages: 17–25